[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354356-105":59,"doc-detail-354356-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-the-functional-impact-of-individual-ddx41-variants-with-a-fast-and-robust-cell-based-method","Exploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method","","Germline DDX41 variants occur in up to 4% of acute myeloid leukemia (AML) and myelodysplastic neoplasms (MDSs) patients, with male enrichment and late onset. The study analyzed 647 Danish patients with suspected myeloid neoplasms to quantify DDX41 variant frequency and the functional effects of variants of uncertain significance (VUSs) using CRISPR-Select. Sixteen variants were found in 30 patients; 14 were germline. Pathogenic variants reduced proliferation and truncating alleles showed stronger impairment than missense variants.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-functional-impact-of-individual-ddx41-variants-with-a-fast-and-robust-cell-based-method/354356/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-functional-impact-of-individual-ddx41-variants-with-a-fast-and-robust-cell-based-method/354356.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How many Danish patients were analyzed and what was the study aim?","Question",{"text":112,"@type":113},"The study analyzed 647 Danish patients with suspected myeloid neoplasms to assess the frequency of germline DDX41 variants and evaluate the functional impact of DDX41 variants of uncertain significance (VUSs).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is CRISPR-Select used for in this research?",{"text":117,"@type":113},"CRISPR-Select was used with a cell-based assay to test how individual DDX41 variants affect cellular proliferation and survival, enabling discrimination between pathogenic and benign variants.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects were observed for pathogenic versus benign DDX41 variants?",{"text":121,"@type":113},"Pathogenic germline variants impaired proliferation, whereas benign variants did not. Missense variants showed a more subtle effect than truncating variants.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354356,1790151823,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Human Mutation  \nRESEARCH ARTICLE  OPEN ACCESS   \nExploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method  \nNikolaj Juul Nitschke1, 2 | Marwa Almosailleakh1, 2 | Issa Ismail Issa1, 2 | Clara Amanda Skov1, 2 | Casper Carstens Lund2 | Jakob Werner Hansen1, 2 | Jakob Schmidt Jespersen2 , 3 | Klas Raaschou-Jensen4 | Claudia Schöllkopf1 | Marianne Tang Severinsen5,6 | Bo Porse2 , 3,7 | Joachim Weischenfeld2 , 3 | Anne Stidsholt Roug8 ,9 | Mette Klarskov Andersen10 | Morten Frödin2 | Kirsten Grønbæk1, 2 ,7  \n1Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark | 2Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark | 3Finsen Laboratory, Copenhagen University HospitalRigshospitalet, Copenhagen, Denmark | 4Department of Hematology, Odense University Hospital, Odense, Denmark | 5Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark | 6Department of Clinical Medicine, Aalborg University, Aalborg, Denmark | 7Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark | 8Department of Hematology, Aarhus University Hospital, Aarhus, Denmark | 9Department of Molecular Medicine, Aarhus University Hospital, Aarhus,  \nDenmark | 10Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Correspondence: Kirsten Grønbæk ([kirsten.groenbaek@regionh.dk](kirsten.groenbaek@regionh.dk))  \nReceived: 2 December 2025 | Revised: 27 April 2026 | Accepted: 11 May 2026  \nAcademic Editor: Feng Gu  \nKeywords: AML | DDX41 | functional genetics | germline predisposition to myeloid neoplasms | MDS | variant interpretation  \nABSTRACT  \nGermline DDX41 variants are found in up to 4% of patients with acute myeloid leukemia (AML) and myelodysplastic neoplasms (MDSs), with a higher prevalence among males and a late onset. In this study, we analyzed 647 Danish patients with suspected myeloid neoplasms to assess the frequency of germline DDX41 variants and the functional impact of variants of uncertain significance (VUSs) using a cell-based assay, CRISPR-Select. We identified 16 DDX41 variants in 30 patients, 14 of whom were confirmed or predicted as germline variants. Eight germline variants were classified as likely pathogenic/pathogenic (LP/P), and three as VUSs. We generated a monoallelic DDX41 K562 cell line and used it for CRISPR-Select assessment of variant effects on proliferation and survival. Pathogenic variants impaired proliferation, while benign variants did not. Missense variants had amore subtle effect than truncating ones, suggesting hypomorphic phenotypes. One DDX41 VUS had a significant negative effect on proliferation, suggesting it to be pathogenic, while the other two had no effect, suggesting them to be benign. These findings confirm a 2.4% frequency of LP/P DDX41 germline variants in Danish patients and demonstrate the value of CRISPR-Select in distinguishing pathogenic from benign variants.  \n1 | Introduction  \nIn 2015, Polprasert et al. identified DDX41 germline variants inpatients with myeloid neoplasms (MNs) [1] . Since then, several studies have examined the frequency of germline DDX41 variants and found that up to 4% of all patients with acute myeloid leukemia (AML) or myelodysplastic neoplasms (MDSs) harbor pathogenic variants. In 2022, Makishima et al. examined 9082  \npatients with MN and identified germline likely pathogenic DDX41 variants (likely pathogenic/pathogenic [LP/P]) in 293 patients (3.2%) [2] . Kovilakam et al. examined the carrier rate of DDX41 variants in the UK Biobank and strikingly found that 1/129 and 1/430 carried a nonsynonymous variant (LP/P)  \n[3] . This makes germline DDX41 variants the most frequent known germline alteration predisposing to the development of MNs. Germline DDX41 variant–associated MNs","cbCaicMjOqDpKA4f","https://ap.wps.com/l/cbCaicMjOqDpKA4f","pdf",1373105,11,"English","# Abstract\n# Introduction\n## Background on DDX41 germline variants\n## Clinical features and prognosis\n## Biological role of DDX41 and need for functional models","[{\"question\":\"How many Danish patients were analyzed and what was the study aim?\",\"answer\":\"The study analyzed 647 Danish patients with suspected myeloid neoplasms to assess the frequency of germline DDX41 variants and evaluate the functional impact of DDX41 variants of uncertain significance (VUSs).\"},{\"question\":\"What is CRISPR-Select used for in this research?\",\"answer\":\"CRISPR-Select was used with a cell-based assay to test how individual DDX41 variants affect cellular proliferation and survival, enabling discrimination between pathogenic and benign variants.\"},{\"question\":\"What functional effects were observed for pathogenic versus benign DDX41 variants?\",\"answer\":\"Pathogenic germline variants impaired proliferation, whereas benign variants did not. Missense variants showed a more subtle effect than truncating variants.\"}]","Exploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method | PDF",1790110267,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e27959d694c0bafa647680b13304a5f.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/911a9b3d2f88a164dfc3281b44cff5c8.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7513b9e5a48b6e14a8f4d7dd93f7da65.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec3a353e9a1ad7b51611525eafdd2e48.webp",980,1287]